Vimarsana
Biggest News Aggregation in the World

Page 2 - Plus Therapeutic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Plus Therapeutic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Plus Therapeutic Today - Breaking & Trending Today

Plus Therapeutics (NASDAQ:PSTV) and Intelligent Bio Solutions (NASDAQ:INBS) Head to Head Survey - Vimarsana News

Plus Therapeutics (NASDAQ:PSTV) and Intelligent Bio Solutions (NASDAQ:INBS) Head to Head Survey

Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) and Plus Therapeutics (NASDAQ:PSTV – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and profitability. Analyst Recommendations This is a breakdown […]

Source: wkrb13.com
Beauty Health (NASDAQ:SKIN) vs. Plus Therapeutics (NASDAQ:PSTV) Critical Survey - Vimarsana News

Beauty Health (NASDAQ:SKIN) vs. Plus Therapeutics (NASDAQ:PSTV) Critical Survey

Beauty Health (NASDAQ:SKIN – Get Free Report) and Plus Therapeutics (NASDAQ:PSTV – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, institutional ownership, valuation and profitability. Earnings & Valuation This table compares Beauty […]

Baystreet.ca - Plus Fails to Find Traction on Licensing Agreement - Vimarsana News

Baystreet.ca - Plus Fails to Find Traction on Licensing Agreement

Plus Therapeutics, Inc. (NASDAQ: PSTV) saw its shares continue static Friday, as the clinical-stage pharmaceutical company announced it has expanded its supply agreement with Biocept by acquiring an option to exclusively license Biocept's CNSide, a CSF-based ...

EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System Cancers - Plus Therapeutics (NASDAQ:PSTV) - Vimarsana News

EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System Cancers - Plus Therapeutics (NASDAQ:PSTV)

Plus Therapeutics Inc (NASDAQ: PSTV) has expanded its supply agreement with Biocept Inc (NASDAQ: BIOC) by acquiring an option to exclusively license Biocept's CNSide, a cerebrospinal flu

Baystreet.ca - Plus Fails to Find Traction on Licensing Agreement - Vimarsana News

Baystreet.ca - Plus Fails to Find Traction on Licensing Agreement

Plus Therapeutics, Inc. (NASDAQ: PSTV) saw its shares continue static Friday, as the clinical-stage pharmaceutical company announced it has expanded its supply agreement with Biocept by acquiring an option to exclusively license Biocept's CNSide, a CSF-based ...